Further evidence shows Omicron causes milder symptoms
January 4, 2022A WHO official has said more evidence is emerging to support that the Omicron variant causes milder symptoms than previous …
Theranos founder Elizabeth Holmes found guilty of fraud
January 4, 2022Manufacturing and Production
Elizabeth Holmes, founder of Theranos, has been found guilty on four of 11 charges of fraud, including one count of …
FDA expands Pfizer COVID-19 booster shot EUA for children aged 12-15
January 4, 2022Manufacturing and Production
The FDA has bypassed its advisory panel and extended its Emergency Use Authorisation (EUA) for Pfizer BioNTech’s COVID-19 booster vaccine …
Santhera enters exclusive license agreement with Sperogenix for Vamorolone in rare diseases
January 4, 2022Manufacturing and Production
Santhera Pharmaceuticals has announced that it has entered into an exclusive license agreement with China-based company, Sperogenix Therapeutics, specialising in …
NICE recommends combination treatment for patients with multiple myeloma
December 24, 2021Medical Communications
NICE has recommended the use of Darzalex (daratumumab) in combination with Velcade (bortezomib), thalidomide and dexamethasone (DVTd) as induction and …
MHRA approves license extension for Novartis’ breast cancer targeted therapy
December 24, 2021Medical Communications
The MHRA has approved the marketing authorisation to extend Novartis’ licence in Great Britain for Piqray (alpelisib), for use in …
Veklury demonstrates reduced risk of hospitalisation in high-risk patients with COVID-19
December 23, 2021Business Services
Gilead Sciences have announced full results from a Phase III investigational study, evaluating the efficacy and safety of a three-day …
FDA approves Novartis’ Cosentyx for psoriatic arthritis patients
December 23, 2021The FDA has approved Cosentyx (secukinumab) for the treatment of active enthesitis-related arthritis (ERA) in children four years and older, …
Avacta lateral flow test receives CE mark for consumer self-testing
December 22, 2021Research and Development
Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® …
South African study suggests Omicron has a lower risk of hospitalisation than Delta
December 22, 2021Research and Development
A new South African study suggests that there are reduced risks of hospitalisation and severe disease in people infected with …
FDA places clinical hold on use of injectable lenacapavir for HIV treatment
December 22, 2021Research and Development
The FDA has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials, in all ongoing clinical …
EMA recommends Nuvaxovid for authorisation, as WHO grants second Emergency Use Listing
December 22, 2021Research and Development
Nuvaxovid™, the COVID-19 vaccine manufactured by the biotechnology company Novavax, has been listed for emergency use by WHO. The news …
FDA approves first injectable treatment for HIV pre-exposure prevention
December 21, 2021Manufacturing and Production
The FDA have approved Apretude (cabotegravir extended-release injectable suspension), for use in at-risk adults and adolescents weighing at least 35 …
Moderna CEO says Omicron booster could begin development within weeks
December 21, 2021Medical Communications
Stephane Bancel, CEO of Moderna, said that the company could begin work on a booster shot against the Omicron variant …
FDA approves bipolar depression treatment for broad range of adults
December 21, 2021Manufacturing and Production
Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialisation of therapeutics for central nervous system (CNS) disorders, have …
Vifor Pharma announces positive results from Phase IIIb trial of heart failure treatment
December 21, 2021Medical Communications
Vifor Pharma has announced positive findings for the completed Phase IIIb DIAMOND trial of Veltassa, in heart failure patients with …
Positive CHMP opinion for sickle cell disease anaemia tablet
December 20, 2021Sales and Marketing
Global Blood Therapeutics (GBT) have announced the CHMP adopted a positive opinion recommending marketing authorisation for Oxbryta® (vocelotor) tablets. Oxbryta …
FDA approval of Tezspire for severe asthma
December 20, 2021Sales and Marketing
Tezpire (tezepelumab-ekko), manufactured by AstraZeneca and Amgen, has been approved in the US for the add-on maintenance treatment of adult …
Study reveals potential link between COVID-19 and Parkinson’s Disease
December 20, 2021Sales and Marketing
Scientists in The Netherlands have detailed a possible correlation between COVID-19 and the onset of Parkinson’s disease. The findings may …
New COVID-19 drug Sotrovimab becomes available on NHS
December 20, 2021Sales and Marketing
Sotrovimab, commercially known as Xevudy, is now available on the NHS to reduce the risk of vulnerable patients needing hospitalisation …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
